ロード中...
Recombinant tissue plasminogen activator for the treatment of acute ischemic stroke
The use of recombinant tissue plasminogen activator (rtPA) has been the standard of care for treatment of acute ischemic stroke for several years. Studies evaluating the efficacy, safety, and optimal timing of rtPA use are ongoing. Recently, results of new studies led to expansion of the short timef...
保存先:
| 第一著者: | |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Baylor Health Care System
2011
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3124916/ https://ncbi.nlm.nih.gov/pubmed/21738304 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|